Naftin
NDC 54766-772, Naftifine Hydrochloride, gel, from Sebela Pharmaceuticals Inc..
- Product NDC
- 54766-772
- Status
- Listed
- Labeler
- Sebela Pharmaceuticals Inc.
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA204286
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/54766-772 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAFTIFINE HYDROCHLORIDE2 g/100g
Pharmacologic classes
Allylamine Antifungal [EPC]; Allylamine [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 54766-772-45 | 54766077245 | 1 TUBE in 1 CARTON (54766-772-45) / 45 g in 1 TUBE |
| 54766-772-60 | 54766077260 | 1 TUBE in 1 CARTON (54766-772-60) / 60 g in 1 TUBE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6645994a-ecb3-277b-e053-2a91aa0a81e5
Use it
Look up 54766-772 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/54766-772 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 54766-772. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.